China Medical GatewayLoading your healthcare gateway…

Yao Yu

Yao Yu — Chief Physician — Neurosurgery — Huashan Hospital Affiliated to Fudan University

Specialties

Skilled in using minimally invasive techniques (including microscope, exoscope, and endoscopic techniques), intraoperative MRI technology, neuronavigation technology, and intraoperative electrophysiological techniques for the surgical treatment of various brain tumors such as functional area gliomas, recurrent gliomas, meningiomas, vestibular schwannomas, metastatic tumors, medulloblastomas, germ cell tumors, and cavernous hemangiomas, including neoadjuvant immunotherapy (such as DC vaccines) for malignant gliomas guided by molecular pathology.

Education

Doctor of Medicine

Professional Experience

Chief Neurosurgeon at Huashan Hospital, Doctor of Medicine, and PhD supervisor. He trained under the renowned neurosurgeon Academician Zhou Liangfu, and is currently the head of the Huashan Neuro-oncology Comprehensive Treatment Ward, deputy leader of the Glioma Subspecialty Group of the Neurosurgery Department at Huashan Hospital, head of the expert group for the consensus formulation of immunotherapy and targeted therapy for central nervous system gliomas in China, secretary and main member of the Chinese Glioma Guidelines Writing Group, secretary of the Chinese Glioma Cooperative Group, and secretary of the National Clinical Key Specialty (Oncology). He is a peer reviewer for journals such as the American Journal of Neuro-Oncology, Chinese Journal of Neurosurgery, and Chinese Medical Journal; a reviewer for the National Natural Science Foundation of China; editorial board member of Modern Neurosurgery and Practical Neurology. He specializes in microsurgical minimally invasive treatment of various brain tumors such as gliomas, metastatic tumors, medulloblastomas, germ cell tumors, and meningiomas, particularly comprehensive treatment strategies for malignant brain tumors guided by molecular pathology, including immunotherapy and tumor-treating fields. He has trained at the renowned Mayo Clinic in the United States (2012, under Professor I.F. Parney, specializing in minimally invasive brain tumor surgery), Dana-Farber Cancer Institute affiliated with Harvard University (2012, under Professor Patrick Y. Wen, specializing in comprehensive treatment of malignant brain tumors), and MD Anderson Cancer Center (2009, under W. K. Alfred Yung and Mark R. Gil).

Professional Roles

Deputy Editor of the Chinese Translation Expert Group of the NCCN Brain Tumor Guidelines, International Member of the U.S. Cancer Moonshot Program; Head of the Chinese Consensus Group on Immunotherapy and Targeted Therapy for Central Nervous System Gliomas; Secretary and Key Member of the Chinese Glioma Guidelines Writing Group; Secretary of the Chinese Glioma Collaborative Group; Reviewer for the Journal of Neuro-Oncology (USA); Reviewer for the Chinese Journal of Neurosurgery; Reviewer for the Chinese Medical Journal; Evaluator for the National Natural Science Foundation of China

Return to Home